Reviewing case reports and the droperidol warning: FDA response
- PMID: 14570686
- DOI: 10.1213/01.ANE.0000077671.77618.F9
Reviewing case reports and the droperidol warning: FDA response
Comment on
-
Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases.Anesth Analg. 2003 May;96(5):1377-1379. doi: 10.1213/01.ANE.0000063923.87560.37. Anesth Analg. 2003. PMID: 12707137 No abstract available.
References
-
- Ashraf SH, Tong JG. Food and Drug Administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003; 96: 1377–9.
-
- Drolet B, Zhang S, Deschenes D, et al. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 1999; 10: 1597–604.
-
- Lischke V, Behne M, Doelken P, et al. Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 1994; 79: 983–6.
-
- Guy JM, Andre-Fouet X, Porte J, et al. Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol [in French]. Ann Cardiol Angeiol (Paris) 1991; 40: 541–5.
-
- Reilly JG, Ayis SA, Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000; 355: 1048–52.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources